
CARsgen Therapeutics Holdings Ltd
HKEX:2171

Income Statement
Earnings Waterfall
CARsgen Therapeutics Holdings Ltd
Revenue
|
39.4m
CNY
|
Cost of Revenue
|
-24.7m
CNY
|
Gross Profit
|
14.7m
CNY
|
Operating Expenses
|
-822.9m
CNY
|
Operating Income
|
-808.2m
CNY
|
Other Expenses
|
10.1m
CNY
|
Net Income
|
-798.1m
CNY
|
Income Statement
CARsgen Therapeutics Holdings Ltd
Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue |
26
N/A
|
26
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
6
N/A
|
39
+522%
|
|
Gross Profit | ||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
(5)
|
(25)
|
|
Gross Profit |
26
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
15
+812%
|
|
Operating Income | ||||||||
Operating Expenses |
(613)
|
(752)
|
(806)
|
(804)
|
(785)
|
(740)
|
(823)
|
|
Selling, General & Administrative |
(124)
|
(119)
|
(130)
|
(131)
|
(119)
|
(132)
|
(160)
|
|
Research & Development |
(468)
|
(603)
|
(627)
|
(620)
|
(587)
|
(533)
|
(466)
|
|
Depreciation & Amortization |
(36)
|
(45)
|
(59)
|
(71)
|
(87)
|
(76)
|
0
|
|
Other Operating Expenses |
14
|
16
|
10
|
18
|
8
|
0
|
(196)
|
|
Operating Income |
(587)
N/A
|
(726)
-24%
|
(806)
-11%
|
(804)
+0%
|
(785)
+2%
|
(739)
+6%
|
(808)
-9%
|
|
Pre-Tax Income | ||||||||
Interest Income Expense |
6
|
6
|
(85)
|
(115)
|
38
|
44
|
10
|
|
Total Other Income |
(4 156)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(4 737)
N/A
|
(719)
+85%
|
(891)
-24%
|
(919)
-3%
|
(747)
+19%
|
(694)
+7%
|
(798)
-15%
|
|
Net Income | ||||||||
Tax Provision |
(8)
|
(8)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(4 744)
|
(727)
|
(892)
|
(920)
|
(748)
|
(695)
|
(798)
|
|
Net Income (Common) |
(4 744)
N/A
|
(727)
+85%
|
(892)
-23%
|
(920)
-3%
|
(748)
+19%
|
(695)
+7%
|
(798)
-15%
|
|
EPS (Diluted) |
-12.26
N/A
|
-1.32
+89%
|
-1.62
-23%
|
-1.66
-2%
|
-1.34
+19%
|
-1.25
+7%
|
-1.44
-15%
|